Skip to Main Content
Michelle L. Hastings

Michelle L. Hastings, PhD

Director, Center for Genetic Diseases

 

  • Michelle L. Hastings – Center Director
    • Molecular approaches towards the treatment of deafness, imbalance, and vision.
    • Use of antisense oligonucleotide technology and small molecule compounds for the treatment of spinal muscular atrophy, hearing impairment and Alzheimer's disease.
  • Robert J. Bridges
    • Identification of potential drug candidates for the treatment of cystic fibrosis.
    • Probing human nasal epithelial cells for in vitropharmacogenomic studies for the treatment of cystic fibrosis.
  • Neil Bradbury
    • The regulation of membrane protein trafficking in cystic fibrosis.
    • Probing human nasal epithelial cells for in vitropharmacogenomic studies for the treatment of cystic fibrosis.
  • David M. Mueller
    • The structure and functional mechanism of the mitochondrial F1F0-ATPase.
    • The folding and structure-function of the cystic fibrosis transmembrane conductance regulator.